Tim Evans analyst

Currently out of the existing stock ratings of Tim Evans, 4 are a HOLD (66.67%), 2 are a BUY (33.33%).

Tim Evans

Work Performance Price Targets & Ratings Chart

Analyst Tim Evans, carries an average stock price target met ratio of 100% that have a potential upside of 8.51% achieved within 81 days. Previously, Tim Evans worked at WELLS FARGO.

Tim Evans’s has documented 12 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CTLT, Catalent at 16-Nov-2023.

Wall Street Analyst Tim Evans

Analyst best performing recommendations are on ILMN (ILLUMINA).
The best stock recommendation documented was for ILMN (ILLUMINA) at 10/25/2017. The price target of $205 was fulfilled within 9 days with a profit of $5.73 (2.88%) receiving and performance score of 3.19.

Average potential price target upside

CRL Charles River Laboratories ILMN Illumina CTLT Catalent BIO Bio-Rad Laboratories QGEN Qiagen NV TMO Thermo Fisher Scientific

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 07-Jun-2024

$200

$-20.91 (-9.47%)

$174

26 days ago
(18-Dec-2025)

6/6 (100%)

$6.15 (3.17%)

44

Buy

Since 02-Oct-2025

$215

$-5.91 (-2.68%)

$210

29 days ago
(15-Dec-2025)

9/9 (100%)

$21.97 (11.38%)

48

Hold

Since 08-Aug-2024

$190

$-30.91 (-13.99%)

$160

29 days ago
(15-Dec-2025)

4/5 (80%)

$-3.03 (-1.57%)

17

Hold

Since 28-Jun-2024

1 months 27 days ago
(17-Nov-2025)

5/7 (71.43%)

$27.87 (10.63%)

136

Buy

Since 10-Nov-2025

$197

$-23.91 (-10.82%)

$105

2 months 3 days ago
(10-Nov-2025)

8/9 (88.89%)

$28.03 (16.59%)

91

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Tim Evans?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?